In the B‐cell context, studies have demonstrated higher levels of circulating CXCR3 expressing B cells in patients with inflammatory disorders, such as rheumatoid arthritis,46 giant cell arteritis and polymyalgia rheumatica.47 Here, CXCR3 is linked to arteritis.